Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kenneth Burkus

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neurosurgery. Spine|April 8, 2017
Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trialTodd H Lanman, J Kenneth Burkus, Randall G Dryer, et al.
Journal of Neurosurgery. Spine|August 1, 2015
Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption studyMatthew F Gornet, J Kenneth Burkus, Mark E Shaffrey, et al.
Journal of Neurosurgery. Spine|May 18, 2019
Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption studyMatthew F Gornet, J Kenneth Burkus, Randall F Dryer, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2009
Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesisJohn R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 15, 2011
Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned"John R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
Spine|February 26, 2009
Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environmentJeffrey M Toth, Scott D Boden, J Kenneth Burkus, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 19, 2009
Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graftJohn R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
Spine|May 15, 2007
SF-36 PCS benefit-cost ratio of lumbar fusion comparison to other surgical interventions: a thought experimentDavid W Polly, Steven D Glassman, James D Schwender, et al.
Journal of Neurosurgery. Spine|June 22, 2019
Two-level cervical disc arthroplasty versus anterior cervical discectomy and fusion: 10-year outcomes of a prospective, randomized investigational device exemption clinical trialMatthew F Gornet, Todd H Lanman, J Kenneth Burkus, et al.
Spine|February 18, 2011
Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spineJ Kenneth Burkus, Matthew F Gornet, Steven D Glassman, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neurosurgery. Spine|April 8, 2017
Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trialTodd H Lanman, J Kenneth Burkus, Randall G Dryer, et al.
Journal of Neurosurgery. Spine|August 1, 2015
Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption studyMatthew F Gornet, J Kenneth Burkus, Mark E Shaffrey, et al.
Journal of Neurosurgery. Spine|May 18, 2019
Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption studyMatthew F Gornet, J Kenneth Burkus, Randall F Dryer, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2009
Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesisJohn R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 15, 2011
Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned"John R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
Spine|February 26, 2009
Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environmentJeffrey M Toth, Scott D Boden, J Kenneth Burkus, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 19, 2009
Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graftJohn R Dimar, Steven D Glassman, J Kenneth Burkus, et al.
Spine|May 15, 2007
SF-36 PCS benefit-cost ratio of lumbar fusion comparison to other surgical interventions: a thought experimentDavid W Polly, Steven D Glassman, James D Schwender, et al.
Journal of Neurosurgery. Spine|June 22, 2019
Two-level cervical disc arthroplasty versus anterior cervical discectomy and fusion: 10-year outcomes of a prospective, randomized investigational device exemption clinical trialMatthew F Gornet, Todd H Lanman, J Kenneth Burkus, et al.
Spine|February 18, 2011
Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spineJ Kenneth Burkus, Matthew F Gornet, Steven D Glassman, et al.
Pageof 5